Department of Microbiology, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi, Tokyo, Japan,Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi, Tokyo, Japan.
Medicine (Baltimore). 2022 Mar 18;101(11). doi: 10.1097/MD.0000000000029070.
Although sleep disorders are common in patients with human immunodeficiency virus (HIV) infection, they have not been adequately evaluated under currently advanced treatments, mainly with integrase strand transfer inhibitors. However, the relationship of sleep disorders with long-term complications and quality of life (QOL) status in patients infected with HIV is still poorly understood. Such associations are important in the management of outpatients with HIV. Hence, this study aimed to evaluate these associations.This cross-sectional observational study assessed the QOL changes of patients with HIV before and after the treatment regimen change. Male patients with well-controlled HIV who attended our hospital and changed HIV medications for reasons other than treatment failure between October 2019 and September 2021 were included. At the time of regimen change, sleep disorder status was assessed according to the Pittsburgh sleep quality index (PSQI), and health-related QOL (HRQOL) was assessed using the medical outcomes study 8-item short form health survey. In addition, we collected information on age, blood tests, and long-term comorbid conditions present during the evaluation. The HIV treatment regimen was also reviewed.Out of 45 male Japanese patients with HIV that were included in this study, 24 (53.3%) and 21 (46.7%) were classified into the sleep disorder group and nonsleep disorder group, respectively, according to their PSQI scores. The sleep disorder group had a significantly lower HRQOL mental component summary (P = .0222) than the nonsleep disorder group. The prevalence rates of hypertension, dyslipidemia, and diabetes mellitus were not significantly different between the 2 groups. In addition, a significant correlation was observed between PSQI scores and the HRQOL status (mental component summary, P = .0450; physical component summary, P = .0350).Sleep disorders remain common in patients with well-controlled HIV infection receiving current treatment. Sleep disorder is significantly associated with a low HRQOL in these patients. Hence, sleep status evaluation is necessary to improve HIV management.
尽管睡眠障碍在人类免疫缺陷病毒 (HIV) 感染患者中很常见,但在目前先进的治疗方法(主要是整合酶链转移抑制剂)下,这些睡眠障碍并未得到充分评估。然而,HIV 感染者的睡眠障碍与长期并发症和生活质量 (QOL) 状况之间的关系仍知之甚少。这些关联对于管理 HIV 门诊患者非常重要。因此,本研究旨在评估这些关联。
这项横断面观察性研究评估了接受治疗方案改变前后 HIV 患者的 QOL 变化。2019 年 10 月至 2021 年 9 月期间,因治疗失败以外的其他原因在我院就诊并改变 HIV 药物的 HIV 控制良好的男性患者纳入本研究。在治疗方案改变时,根据匹兹堡睡眠质量指数 (PSQI) 评估睡眠障碍状况,并使用医疗结局研究 8 项简短健康调查评估与健康相关的 QOL (HRQOL)。此外,我们收集了评估期间的年龄、血液检查和长期合并症信息。还回顾了 HIV 治疗方案。
在本研究纳入的 45 名日本男性 HIV 患者中,根据 PSQI 评分,24 名(53.3%)和 21 名(46.7%)患者分别被归类为睡眠障碍组和非睡眠障碍组。睡眠障碍组的 HRQOL 心理成分综合评分明显低于非睡眠障碍组(P =.0222)。两组高血压、血脂异常和糖尿病的患病率无显著差异。此外,PSQI 评分与 HRQOL 状况(心理成分综合评分,P =.0450;生理成分综合评分,P =.0350)呈显著相关性。
目前的治疗方法下,睡眠障碍在接受治疗的 HIV 感染控制良好的患者中仍然很常见。睡眠障碍与这些患者的低 HRQOL 显著相关。因此,评估睡眠状态对于改善 HIV 管理非常必要。